Medical and Scientific: High costs are bad medicine

11 Jan 2021 - Medical and Scientific

Almost 50 high-cost medicines have been approved for government subsidy but never made it on to the Pharmaceutical Benefits Scheme, an investigation by The West Australian has found. And the problem is about to get worse under new reference pricing rules in the US that mean pharmaceutical companies will have no incentive to give cheap drugs to Australians. The 46 medicines include those used for treating cancer, migraine, rheumatoid arthritis, osteoporosis and heart disease. A government subsidy would slash the price patients pay for these medicines from up to $6000 a month to just $41.30 for general patients and $6.60 for pensioners.

The West Australian; 09/01/2021; Page 24; Courier Mail; 09/01/21; Page 29; Daily Telegraph; 09/01/2021; Page 74; Adelaide Advertiser; 09/01/2021; Page 18